Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Programs for responding after patients are harmed by their healthcare: A Making Healthcare Safer IV rapid review.

Journal of patient safety and risk management·2026
Same author

Catching the Wave: AI In Health Services Research.

Learning health systems·2026
Same author

Editorial: Responding to harm with compassion, accountability, and transparency.

Frontiers in health services·2026
Same author

Supporting Health Care Workers After Medical Error: Considerations for Health Care Leaders.

Journal of clinical outcomes management : JCOM·2026
Same author

Promoting Fairness in Screening Programs for Late-Career Practitioners.

The New England journal of medicine·2026
Same author

Ten Reasons Why Learning Health Systems Will Have a Transformational Effect on Health and Health Care.

Learning health systems·2025

関連する実験動画

Updated: Jun 18, 2026

Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

生物医学研究への参加

Sarah M Greene, Kathleen M Mazor, Thomas H Gallagher

    JAMA
    |November 26, 2009
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
    08:01

    Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

    Published on: November 30, 2022

    Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
    06:42

    Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

    Published on: September 2, 2025

    関連する実験動画

    Last Updated: Jun 18, 2026

    Working with Human Tissues for Translational Cancer Research
    07:48

    Working with Human Tissues for Translational Cancer Research

    Published on: November 26, 2015

    Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
    08:01

    Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

    Published on: November 30, 2022

    Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
    06:42

    Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

    Published on: September 2, 2025